Glucagon-like peptide-1 (GLP-1) protects against methylglyoxal-induced PC12 cell apoptosis through the PI3K/Akt/mTOR/GCLc/redox signaling pathway
- 1 September 2009
- journal article
- Published by Elsevier in Neuroscience
- Vol. 162 (4) , 1212-1219
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 DiabetesDiabetes Care, 2009
- Mutated recombinant human glucagon-like peptide-1 protects SH-SY5Y cells from apoptosis induced by amyloid-β peptide (1–42)Neuroscience Letters, 2008
- Prevalence of Alzheimer's disease with diabetes in the Japanese populationPsychogeriatrics, 2008
- Growing roles for the mTOR pathwayCurrent Opinion in Cell Biology, 2005
- Methylglyoxal administration induces diabetes-like microvascular changes and perturbs the healing process of cutaneous woundsClinical Science, 2005
- TOR of the cell cycle: Are there important implications for diabetics in the era of the drug‐eluting stent?Catheterization and Cardiovascular Interventions, 2004
- Glucagon‐like peptide‐1 decreases endogenous amyloid‐β peptide (Aβ) levels and protects hippocampal neurons from death induced by Aβ and ironJournal of Neuroscience Research, 2003
- Protection and Reversal of Excitotoxic Neuronal Damage by Glucagon-Like Peptide-1 and Exendin-4The Journal of Pharmacology and Experimental Therapeutics, 2002
- Long Exposure to High Glucose Concentration Impairs the Responsive Expression of γ-Glutamylcysteine Synthetase by Interleukin-1β and Tumor Necrosis Factor-α in Mouse Endothelial CellsJournal of Biological Chemistry, 1996
- Structural Characterization by Affinity Cross‐Linking of Glucagon‐Like Peptide‐1(7–36)Amide Receptor in Rat BrainJournal of Neurochemistry, 1995